ArticleFrontiers in microbiology2022

Circulating soluble CD36 as a novel biomarker for progression and prognosis of HBV-related liver diseases.

Chunxian Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.